CoChat

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice

Open access

Abstract

Exposure to chronic stress or elevated glucocorticoid hormone levels in adult life has been associated with cognitive deficits and an increased risk for Alzheimer’s disease (AD). Since exposure to stress during early life enhances stress-responsiveness and lastingly affects cognition in adult life, we here investigated; (i) whether chronic early life stress (ELS) affects AD pathology and cognition in middle-aged APPswe/PS1dE9 mice, and (ii) whether it is still possible to rescue these late effects by briefly blocking glucocorticoid receptors (GRs) at a translationally relevant, middle age. Transgenic APPswe/PS1dE9 mice were subjected to ELS by housing dams and pups with limited nesting and bedding material from postnatal days 2–9 only. In 6- and 12-month-old offspring, this resulted in enhanced hippocampal amyloid-β (Aβ)-40 and -42 levels, and in reduced cognitive flexibility, that correlated well with the Aβ42 levels. In parallel, CORT levels and BACE1 levels were significantly elevated. Surprisingly, blocking GRs for only 3 days at 12 months of age reduced CORT levels, reduced hippocampal Aβ40 and -42, and β-site APP-cleaving enzyme 1 (BACE1) levels, and notably rescued the cognitive deficits in 12-month-old APPswe/PS1dE9 mice. These mouse data demonstrate that exposure to stress during the sensitive period early in life influences later amyloid pathology and cognition in genetically predisposed, mutant mice, and as such, may increase AD vulnerability. The fact that a short treatment with a GR antagonist at middle age lastingly reduced Aβ levels and rescued the cognitive deficits after ELS, highlights the therapeutic potential of this drug for reducing amyloid pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0101-2

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Hippocampal amyloid pathology in male APPswe/PS1dE9 mice. a The levels of SDS-soluble Aβ40 and Aβ42 are elevated as a consequence of ELS at 6 months. b At 12 months of age, ELS led to an elevation in Aβ42 levels, but not in Aβ40 levels. c, d No difference was observed between Ctrl and ELS mice for full-length APP levels as measured with 6E10 antibody at 100 kDa at 6 months (c) and 12 months (d). (e) ELS significantly increased amyloid plaque load as measured with 6E10 antibody in the subiculum, but not in the dentate gyrus and cornu ammonis (CA) 1, 2 and 3 areas at 6 months. f ELS did not affect plaque load in the subiculum, dentate gyrus or CA areas at 12 months. g, h BACE1 expression was significantly increased in ELS-APPswe/PS1dE9 mice at 6 (g) and 12 months (h). Six months: Ctrl, N = 5 and ELS, N = 8–10; 12 months: Ctrl, N = 7–9 and ELS, N = 8–9 mice/group
Fig. 1 Hippocampal amyloid pathology in male APPswe/PS1dE9 mice. a The levels of SDS-soluble Aβ40 and Aβ42 are elevated as a consequence of ELS at 6 months. b At 12 months of age, ELS led to an elevation in Aβ42 levels, but not in Aβ40 levels. c, d No difference was observed between Ctrl and ELS mice for full-length APP levels as measured with 6E10 antibody at 100 kDa at 6 months (c) and 12 months (d). (e) ELS significantly increased amyloid plaque load as measured with 6E10 antibody in the subiculum, but not in the dentate gyrus and cornu ammonis (CA) 1, 2 and 3 areas at 6 months. f ELS did not affect plaque load in the subiculum, dentate gyrus or CA areas at 12 months. g, h BACE1 expression was significantly increased in ELS-APPswe/PS1dE9 mice at 6 (g) and 12 months (h). Six months: Ctrl, N = 5 and ELS, N = 8–10; 12 months: Ctrl, N = 7–9 and ELS, N = 8–9 mice/groupCC BY · PubMed Central
Fig. 2 Barnes maze performance of 6-month-old WT and APPswe/PS1dE9 mice. a Schematic overview of the experimental design. b Acquisition learning was comparable between all four groups. All groups display a significant learning curve over the trials. c No difference in the average time to find the exit hole. d During the probe trial all groups spend significantly more than 25% of the time in the quadrant where the exit hole was located. ELS-APPswe/PS1dE9 mice spend significantly less time in the exit quadrant than ELS-WT mice. e During reversal learning, all groups show comparable latencies to find the exit hole, and all groups had a significant decrease in latency over the days. f No differences were observed in the average time to find the exit hole. g On the probe trial after reversal learning, only WT mice spend more than 25% of the total time in the exit quadrant. N = 8–12 mice/group. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance level
Fig. 2 Barnes maze performance of 6-month-old WT and APPswe/PS1dE9 mice. a Schematic overview of the experimental design. b Acquisition learning was comparable between all four groups. All groups display a significant learning curve over the trials. c No difference in the average time to find the exit hole. d During the probe trial all groups spend significantly more than 25% of the time in the quadrant where the exit hole was located. ELS-APPswe/PS1dE9 mice spend significantly less time in the exit quadrant than ELS-WT mice. e During reversal learning, all groups show comparable latencies to find the exit hole, and all groups had a significant decrease in latency over the days. f No differences were observed in the average time to find the exit hole. g On the probe trial after reversal learning, only WT mice spend more than 25% of the total time in the exit quadrant. N = 8–12 mice/group. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance levelCC BY · PubMed Central
Fig. 3 Barnes maze performance of 12-month-old WT and APPswe/PS1dE9 mice. a Acquisition learning was significantly slower in APPswe/PS1dE9 mice compared to WT mice on days 2, 3 and 4. All groups showed a significant learning curve over the trials. b The average time to locate the exit hole was higher in APPswe/PS1dE9 mice, with significant post hoc differences between Ctrl-WT and Ctrl-APPswe/PS1dE9 mice, and between ELS-WT and ELS-APPswe/PS1dE9 mice. c On the probe trial, Ctrl-APPswe/PS1dE9 mice performed significantly worse than Ctrl-WT mice. d During reversal learning, there was a significant difference between the groups on day 2, 3 and 4 in the latency to find the exit hole. Overall, all groups showed a significant learning curve, except for ELS-APPswe/PS1dE9 mice. e The average time to locate the exit hole was higher in the ELS-APPswe/PS1dE9 mice compared to Ctrl-APPswe/PS1dE9 mice, and compared to ELS-WT mice. f On the probe trial, ELS-APPswe/PS1dE9 mice were the only group that did not spend more than 25% of the total time in the exit quadrant. g A typical search pattern of APPswe/PS1dE9 mice reared under control (left) or ELS (right) conditions. h Performance on the final trial during acquisition learning of the Barnes maze correlated significantly with Aβ42 levels (r = 0.69, p < 0.05). i Performance on the second trial of reversal learning of the Barnes maze correlated significantly with Aβ42 levels in APPswe/PS1dE9 mice (r = 0.62, p < 0.05). N = 8–18 mice/group. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance level
Fig. 3 Barnes maze performance of 12-month-old WT and APPswe/PS1dE9 mice. a Acquisition learning was significantly slower in APPswe/PS1dE9 mice compared to WT mice on days 2, 3 and 4. All groups showed a significant learning curve over the trials. b The average time to locate the exit hole was higher in APPswe/PS1dE9 mice, with significant post hoc differences between Ctrl-WT and Ctrl-APPswe/PS1dE9 mice, and between ELS-WT and ELS-APPswe/PS1dE9 mice. c On the probe trial, Ctrl-APPswe/PS1dE9 mice performed significantly worse than Ctrl-WT mice. d During reversal learning, there was a significant difference between the groups on day 2, 3 and 4 in the latency to find the exit hole. Overall, all groups showed a significant learning curve, except for ELS-APPswe/PS1dE9 mice. e The average time to locate the exit hole was higher in the ELS-APPswe/PS1dE9 mice compared to Ctrl-APPswe/PS1dE9 mice, and compared to ELS-WT mice. f On the probe trial, ELS-APPswe/PS1dE9 mice were the only group that did not spend more than 25% of the total time in the exit quadrant. g A typical search pattern of APPswe/PS1dE9 mice reared under control (left) or ELS (right) conditions. h Performance on the final trial during acquisition learning of the Barnes maze correlated significantly with Aβ42 levels (r = 0.69, p < 0.05). i Performance on the second trial of reversal learning of the Barnes maze correlated significantly with Aβ42 levels in APPswe/PS1dE9 mice (r = 0.62, p < 0.05). N = 8–18 mice/group. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance levelCC BY · PubMed Central
Fig. 4 HPA axis activity is affected by early life experiences and a transgenic background at 12 months of age. a In 12-month-old mice, ELS-APPswe/PS1dE9 mice have elevated CORT levels 30 and 90 min after a stressor compared to Ctrl-APPswe/PS1dE9 mice and ELS-WT mice. b The overall CORT exposure after a stressor is higher in 12-month-old ELS-APPswe/PS1dE9 mice compared to all other groups. ELS-WT mice have lower CORT levels than Ctrl-WT mice and ELS-APPswe/PS1dE9 mice. c CORT levels are significantly correlated to performance on trial 1.2 of the reversal learning phase of the Barnes maze (r = 0.40, N = 44, p = 0.01). N = 8–18 mice/group. *Significant post hoc Tukey test
Fig. 4 HPA axis activity is affected by early life experiences and a transgenic background at 12 months of age. a In 12-month-old mice, ELS-APPswe/PS1dE9 mice have elevated CORT levels 30 and 90 min after a stressor compared to Ctrl-APPswe/PS1dE9 mice and ELS-WT mice. b The overall CORT exposure after a stressor is higher in 12-month-old ELS-APPswe/PS1dE9 mice compared to all other groups. ELS-WT mice have lower CORT levels than Ctrl-WT mice and ELS-APPswe/PS1dE9 mice. c CORT levels are significantly correlated to performance on trial 1.2 of the reversal learning phase of the Barnes maze (r = 0.40, N = 44, p = 0.01). N = 8–18 mice/group. *Significant post hoc Tukey testCC BY · PubMed Central
Fig. 5 Three-day treatment with mifepristone lowers CORT levels, reduces Aβ pathology and improves spatial memory in ELS-APPswe/PS1dE9 mice. a Time schedule of the experiment. b Basal CORT levels are reduced 24 h after the last mifepristone treatment (N = 5 mice/group). c In response to an acute stressor, mifepristone treatment reduced plasma CORT levels (N = 8–10 mice/group). d Twenty-four hours after the last treatment, mifepristone treatment reduced hippocampal Aβ40 and Aβ42 levels (N = 4–5 mice/group). e BACE1 expression is reduced 24 h after the last mifepristone treatment. f Twenty-one days after the last treatment, no differences in basal CORT levels were observed. g Twenty-one days after the last treatment, there were no differences in the levels of Aβ40 between the groups. Aβ42 levels remained lower after mifepristone treatment, with significant post hoc tests between the ELS groups. h Twenty-one days after the mifepristone treatment, no differences are observed in the expression of BACE1. i In WT mice, mifepristone treatment had no effect on acquisition learning on the Barnes maze, and all mice learned to locate the exit hole. j In APPswe/PS1dE9 mice, mifepristone treatment resulted in a decreased time to locate the exit hole. k During the probe trial, all groups spend significantly more than 25% of the time in the exit quadrant. l In WT mice, mifepristone treatment had no effect on reversal learning. m In APPswe/PS1dE9 mice, mifepristone treatment resulted in a decreased time to locate the exit hole, specifically in ELS-APPswe/PS1dE9 mice. All mice treated with mifepristone learned to locate the exit hole; vehicle treated mice did not. n In the probe trial of the reversal learning, mifepristone treatment resulted in an increase in the time spend in the exit quadrant. Post hoc Tukey revealed a significant difference between ELS-APPswe/PS1dE9-veh and ELS-APPswe/PS1dE9-mifepristone mice. All experiments at 21 days used N = 7–13 mice/group. Mif. mifepristone. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance level
Fig. 5 Three-day treatment with mifepristone lowers CORT levels, reduces Aβ pathology and improves spatial memory in ELS-APPswe/PS1dE9 mice. a Time schedule of the experiment. b Basal CORT levels are reduced 24 h after the last mifepristone treatment (N = 5 mice/group). c In response to an acute stressor, mifepristone treatment reduced plasma CORT levels (N = 8–10 mice/group). d Twenty-four hours after the last treatment, mifepristone treatment reduced hippocampal Aβ40 and Aβ42 levels (N = 4–5 mice/group). e BACE1 expression is reduced 24 h after the last mifepristone treatment. f Twenty-one days after the last treatment, no differences in basal CORT levels were observed. g Twenty-one days after the last treatment, there were no differences in the levels of Aβ40 between the groups. Aβ42 levels remained lower after mifepristone treatment, with significant post hoc tests between the ELS groups. h Twenty-one days after the mifepristone treatment, no differences are observed in the expression of BACE1. i In WT mice, mifepristone treatment had no effect on acquisition learning on the Barnes maze, and all mice learned to locate the exit hole. j In APPswe/PS1dE9 mice, mifepristone treatment resulted in a decreased time to locate the exit hole. k During the probe trial, all groups spend significantly more than 25% of the time in the exit quadrant. l In WT mice, mifepristone treatment had no effect on reversal learning. m In APPswe/PS1dE9 mice, mifepristone treatment resulted in a decreased time to locate the exit hole, specifically in ELS-APPswe/PS1dE9 mice. All mice treated with mifepristone learned to locate the exit hole; vehicle treated mice did not. n In the probe trial of the reversal learning, mifepristone treatment resulted in an increase in the time spend in the exit quadrant. Post hoc Tukey revealed a significant difference between ELS-APPswe/PS1dE9-veh and ELS-APPswe/PS1dE9-mifepristone mice. All experiments at 21 days used N = 7–13 mice/group. Mif. mifepristone. * indicates a significant post hoc Tukey test. # indicates a significant learning curve over the days. ^ indicates significant performance compared to chance levelCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 85

Metadata

Authors
Lesuis, S. L., Weggen, S., Baches, S., Lucassen, P. J., & Krugers, H. J.
Affiliations
  • University of Amsterdam (NL)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
Lesuis, Sylvie L
Venue
Translational Psychiatry
Published
2018-03-01
Volume
8
Issue
1
Pages
53-53
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2802451112
Cited by
85
References
52
Citations by year
2026: 5 · 2025: 7 · 2024: 14 · 2023: 11 · 2022: 12 · 2021: 10 · 2020: 8 · 2019: 13 · 2018: 5
FWCI
6.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Internationale Stichting Alzheimer Onderzoek (12534)
  • Alzheimer Nederland (12534)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
early life stress, glucocorticoid receptor antagonism, Alzheimer's disease, amyloid-beta, APP/PS1 mice, cognitive flexibility, hippocampus, BACE1, corticosterone, glucocorticoid stress response
MeSH terms
Age Factors, Animals, Behavior, Animal, Corticosterone, Disease Models, Animal, Female, Hippocampus, Hormone Antagonists, Male, Mice, Inbred C57BL, Mice, Transgenic, Peptide Fragments, Receptors, Glucocorticoid, Stress, Psychological, Mifepristone, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Mice, Amyloid Precursor Protein Secretases, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice. https://app.cochat.ai/papers/10.1038/s41398-018-0101-2
The paper
Lesuis, S. L., Weggen, S., Baches, S., Lucassen, P. J., & Krugers, H. J. (2018). Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0101-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.